What does the evidence say about Sodium Bicarbonate Performance Meta-Analysis?

The current Migaku evidence database contains 2 reusable source documents for Sodium Bicarbonate Performance Meta-Analysis. This answer focuses on benefits, uncertainty, and practical interpretation. - Dose-dependent effects of sodium bicarbonate supplementation combined with sprint interval training on performance adaptations in basketball players: a randomized placebo-controlled trial [Wang X (2026); evidence level 2] - −1 − + −1 −1 −1 1 1 2 4 2 Sodium bicarbonate (SB), commonly known as baking soda, is an extracellular buffering agent with increasing research evidence supporting its use as an ergogenic aid. [Antonio Brandi (2026); evidence level 3] - These results showed that the acidosis response associated with the exercise task significantly reduced the blood's buffering capacity and its ability to buffer the increase in hydrogen ions (H) associated with lactate accumulation, resultantly limiting the runner's endurance capacity. [Antonio Brandi (2026); evidence level 3] - 3 4 5–7 There is robust evidence supporting the ergogenic effects of SB on exercise performance []; however, the potential gastrointestinal symptoms (GIS) associated with the compound likely reduces its usage amongst athletes []. [Antonio Brandi (2026); evidence level 3] - It is commonly ingested in doses from 0.2 to 0.5 g·kgbody mass (BM) and intended to improve performance that utilizes non-oxidative metabolism. [Antonio Brandi (2026); evidence level 3] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.